NEKTAR THERAPEUTICS Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Nektar Therapeutics quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • Nektar Therapeutics Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.7M, a 161% decline year-over-year.
  • Nektar Therapeutics Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$15.3M, a 89.5% decline year-over-year.
  • Nektar Therapeutics annual Nonoperating Income (Expense) for 2023 was -$12.6M, a 212% decline from 2022.
  • Nektar Therapeutics annual Nonoperating Income (Expense) for 2022 was $11.2M.
  • Nektar Therapeutics annual Nonoperating Income (Expense) for 2021 was -$77.2M, a 310% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$15.3M -$2.7M -$1.67M -161% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$13.6M -$2.54M -$1.97M -346% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$11.6M -$1.41M +$961K +40.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$12.6M -$8.6M -$4.52M -111% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$8.05M -$1.03M +$3.87M +78.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$11.9M -$570K +$5.56M +90.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$17.5M -$2.37M -$28.7M -109% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $11.2M -$4.08M +$28.7M +87.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$17.5M -$4.9M +$11.1M +69.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$28.6M -$6.13M +$8.83M +59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$37.4M $26.3M +$39.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$77.2M -$32.7M -$26.4M -415% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$50.8M -$16M -$10.5M -190% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$40.3M -$15M -$12.8M -597% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$27.5M -$13.5M -$8.66M -180% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$18.8M -$6.35M -$4.11M -183% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$14.7M -$5.52M -$5.77M -2271% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$8.96M -$2.15M -$2.93M -374% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$6.03M -$4.82M -$6.01M -504% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$19K -$2.25M -$2.49M -1018% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $2.47M $254K -$1.34M -84% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $3.81M $783K -$962K -55.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $4.77M $1.19M +$9.98M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$5.21M $245K +$9.86M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$15.1M $1.59M +$10M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$25.1M $1.75M +$10.9M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$35.9M -$8.79M +$508K +5.47% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$36.4M -$9.61M +$1K +0.01% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$36.4M -$8.41M +$1.77M +17.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$38.2M -$9.12M +$1.04M +10.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$39.2M -$9.3M +$551K +5.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$39.8M -$9.61M +$15.1M +61.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$54.9M -$10.2M -$1.65M -19.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$53.3M -$10.2M -$1.13M -12.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$52.1M -$9.85M -$837K -9.29% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$51.3M -$24.7M -$15.4M -165% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$35.9M -$8.53M +$938K +9.91% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 -$36.8M -$9.02M +$502K +5.27% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$37.3M -$9.01M +$598K +6.22% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$37.9M -$9.34M +$787K +7.77% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$38.7M -$9.47M +$357K +3.63% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$39.1M -$9.53M +$412K +4.15% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$39.5M -$9.61M +$139K +1.43% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 -$39.6M -$10.1M -$550K -5.74% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-01
Q3 2013 -$39.1M -$9.83M +$600K +5.76% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$39.7M -$9.94M -$2.73M -38% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 -$37M -$9.75M -$6.71M -221% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$30.2M -$9.58M -$7.27M -315% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 -$23M -$10.4M -$7.79M -295% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$15.2M -$7.2M -$5.15M -250% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$10M -$3.04M -$1.02M -50.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$9.02M -$2.31M -$532K -29.9% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-27
Q3 2011 -$8.49M -$2.64M -$430K -19.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$8.06M -$2.06M +$296K +12.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$8.36M -$2.02M +$445K +18.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 -$8.8M -$1.78M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-01
Q3 2010 -$2.21M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$2.35M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
Q1 2010 -$2.46M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.